4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-17-049764
See Remarks returned 300,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KINGSLEY ALFRED D See Remarks | 2017-08-17 | Returned to the company | −300,000 | $2.81 | $843,000 | 5,481,555 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…